An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...
Search Results
These tables are special analyses that include opioid use (or heroin use and prescription pain reliever misuse) or opioid use disorders as a variable. The NSDUH survey years used, as well as by-demographic group analyses, vary.